The Latest in Psoriatic Arthritis

Continuing ixekizumab superior to withdrawal in stable psoriatic arthritis

April 5, 2021

Psoriatic Arthritis

PsA: Brodalumab demonstrates favorable efficacy in phase 3 trials

April 5, 2021

Psoriatic Arthritis

Is pain linked to mortality risk in patients with psoriatic arthritis?

April 5, 2021

Psoriatic Arthritis

Rheumatology News

Experts highlight recent breakthroughs in psoriatic arthritis

March 29, 2021

Psoriatic Arthritis

Rheumatology News

COVID-19 vaccination in RMD patients: Safety data “reassuring”

March 29, 2021

Rheumatology News

FDA warning letters target OTC cannabidiol product claims for pain relief

March 25, 2021

Rheumatology News

Checkpoint inhibitor–induced rheumatic complications often arise late

March 15, 2021

Rheumatology News

To improve psoriatic arthritis outcomes, address common comorbidities

March 12, 2021

Psoriatic Arthritis

Rheumatology News

Recent psoriasis pathophysiology insights carry treatment implications

March 4, 2021

Psoriatic Arthritis

Rheumatology News

Methotrexate-associated hepatotoxicity risk differs between psoriasis, PsA, and RA patients

February 25, 2021

Rheumatology News

COVID-19 vaccination recommended for rheumatology patients

February 24, 2021

Rheumatology News

Pandemic puts patients with psoriatic disease off seeking medical help

February 23, 2021

Rheumatology News

Psoriasis registry study finds normal pregnancy outcomes

February 12, 2021

Psoriatic Arthritis

Rheumatology News

Anybody for a nanobody? Novel psoriasis therapy impresses in phase 2b

February 10, 2021

Psoriatic Arthritis

Rheumatology News

Rheumatologic disease activity an important influencer of COVID-19 death risk

February 5, 2021